Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Toll-like receptor 3 ligand, polyIC, induces proteinuria and glomerular CD80, and increases urinary CD80 in mice.

Ishimoto T, Shimada M, Gabriela G, Kosugi T, Sato W, Lee PY, Lanaspa MA, Rivard C, Maruyama S, Garin EH, Johnson RJ.

Nephrol Dial Transplant. 2013 Jun;28(6):1439-46. doi: 10.1093/ndt/gfs543. Epub 2012 Dec 21.

2.

Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-κB-dependent pathway.

Shimada M, Ishimoto T, Lee PY, Lanaspa MA, Rivard CJ, Roncal-Jimenez CA, Wymer DT, Yamabe H, Mathieson PW, Saleem MA, Garin EH, Johnson RJ.

Nephrol Dial Transplant. 2012 Jan;27(1):81-9. doi: 10.1093/ndt/gfr271. Epub 2011 May 26.

3.

Fn14 in podocytes and proteinuric kidney disease.

Sanchez-Niño MD, Poveda J, Sanz AB, Mezzano S, Carrasco S, Fernandez-Fernandez B, Burkly LC, Nair V, Kretzler M, Hodgin JB, Ruiz-Ortega M, Selgas R, Egido J, Ortiz A.

Biochim Biophys Acta. 2013 Dec;1832(12):2232-43. doi: 10.1016/j.bbadis.2013.08.010. Epub 2013 Aug 30.

4.

Serum from minimal change patients in relapse increases CD80 expression in cultured podocytes.

Ishimoto T, Cara-Fuentes G, Wang H, Shimada M, Wasserfall CH, Winter WE, Rivard CJ, Araya CE, Saleem MA, Mathieson PW, Johnson RJ, Garin EH.

Pediatr Nephrol. 2013 Sep;28(9):1803-12. doi: 10.1007/s00467-013-2498-4. Epub 2013 May 21.

5.

Minimal change disease: a CD80 podocytopathy?

Ishimoto T, Shimada M, Araya CE, Huskey J, Garin EH, Johnson RJ.

Semin Nephrol. 2011 Jul;31(4):320-5. doi: 10.1016/j.semnephrol.2011.06.002. Review.

PMID:
21839364
6.

Minimal change disease: a dysregulation of the podocyte CD80-CTLA-4 axis?

Cara-Fuentes G, Wasserfall CH, Wang H, Johnson RJ, Garin EH.

Pediatr Nephrol. 2014 Dec;29(12):2333-40. doi: 10.1007/s00467-014-2874-8. Epub 2014 Jul 14.

7.

Activation of Notch3 in Glomeruli Promotes the Development of Rapidly Progressive Renal Disease.

El Machhour F, Keuylian Z, Kavvadas P, Dussaule JC, Chatziantoniou C.

J Am Soc Nephrol. 2015 Jul;26(7):1561-75. doi: 10.1681/ASN.2013090968. Epub 2014 Nov 24.

PMID:
25421557
8.

Minimal change disease: a "two-hit" podocyte immune disorder?

Shimada M, Araya C, Rivard C, Ishimoto T, Johnson RJ, Garin EH.

Pediatr Nephrol. 2011 Apr;26(4):645-9. doi: 10.1007/s00467-010-1676-x. Epub 2010 Oct 30.

PMID:
21052729
9.

Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.

Fuchshofer R, Ullmann S, Zeilbeck LF, Baumann M, Junglas B, Tamm ER.

Histochem Cell Biol. 2011 Sep;136(3):301-19. doi: 10.1007/s00418-011-0844-9. Epub 2011 Aug 4.

PMID:
21814837
10.

Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.

Garin EH, Mu W, Arthur JM, Rivard CJ, Araya CE, Shimada M, Johnson RJ.

Kidney Int. 2010 Aug;78(3):296-302. doi: 10.1038/ki.2010.143. Epub 2010 May 19.

11.

Urinary CD80 excretion increases in idiopathic minimal-change disease.

Garin EH, Diaz LN, Mu W, Wasserfall C, Araya C, Segal M, Johnson RJ.

J Am Soc Nephrol. 2009 Feb;20(2):260-6. doi: 10.1681/ASN.2007080836. Epub 2008 Dec 3.

12.

Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.

Fujimura T, Yamagishi S, Ueda S, Fukami K, Shibata R, Matsumoto Y, Kaida Y, Hayashida A, Koike K, Matsui T, Nakamura K, Okuda S.

Nephrol Dial Transplant. 2009 May;24(5):1397-406. doi: 10.1093/ndt/gfn659. Epub 2008 Nov 28.

13.

Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.

Agrawal V, Prasad N, Jain M, Pandey R.

Clin Exp Nephrol. 2013 Dec;17(6):811-8. doi: 10.1007/s10157-013-0775-y. Epub 2013 Feb 2.

PMID:
23377573
14.

CD80, suPAR and nephrotic syndrome in a case of NPHS2 mutation.

Cara-Fuentes G, Araya C, Wei C, Rivard C, Ishimoto T, Reiser J, Johnson RJ, Garin EH.

Nefrologia. 2013;33(5):727-31. doi: 10.3265/Nefrologia.pre2013.Jun.12085.

15.

Gα12 activation in podocytes leads to cumulative changes in glomerular collagen expression, proteinuria and glomerulosclerosis.

Boucher I, Yu W, Beaudry S, Negoro H, Tran M, Pollak MR, Henderson JM, Denker BM.

Lab Invest. 2012 May;92(5):662-75. doi: 10.1038/labinvest.2011.198. Epub 2012 Jan 16.

16.

Induction of B7-1 in podocytes is associated with nephrotic syndrome.

Reiser J, von Gersdorff G, Loos M, Oh J, Asanuma K, Giardino L, Rastaldi MP, Calvaresi N, Watanabe H, Schwarz K, Faul C, Kretzler M, Davidson A, Sugimoto H, Kalluri R, Sharpe AH, Kreidberg JA, Mundel P.

J Clin Invest. 2004 May;113(10):1390-7.

17.

1,25-dihydroxyvitamin D(3) inhibits podocyte uPAR expression and reduces proteinuria.

Ma J, Zhang B, Liu S, Xie S, Yang Y, Ma J, Deng Y, Wang W, Xu L, Li R, Zhang L, Yu C, Shi W.

PLoS One. 2013 May 31;8(5):e64912. doi: 10.1371/journal.pone.0064912. Print 2013.

18.

Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.

Tarabra E, Giunti S, Barutta F, Salvidio G, Burt D, Deferrari G, Gambino R, Vergola D, Pinach S, Perin PC, Camussi G, Gruden G.

Diabetes. 2009 Sep;58(9):2109-18. doi: 10.2337/db08-0895. Epub 2009 Jul 8.

19.

Inhibition of type I interferon signalling prevents TLR ligand-mediated proteinuria.

Gurkan S, Cabinian A, Lopez V, Bhaumik M, Chang JM, Rabson AB, Mundel P.

J Pathol. 2013 Oct;231(2):248-56.

PMID:
24151637
20.

Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.

Wagrowska-Danilewicz M, Stasikowska O, Danilewicz M.

Pol J Pathol. 2006;57(1):17-21.

PMID:
16739878
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk